UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000022956 |
|---|---|
| Receipt number | R000026318 |
| Scientific Title | A Phase II study of Ramucirumab beyond disease progression in combination with Irinotecan after failure of weekly Paclitaxel plus Ramucirumab in advanced gastric cancer patients previously treated with fluoropyrimidine and platinum |
| Date of disclosure of the study information | 2016/07/01 |
| Last modified on | 2022/11/13 17:00:00 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/06/30 19:45:42 | ||
| 2 | Update | 2016/06/30 19:46:20 | UMIN ID1 UMIN ID2 |
|
| 3 | Update | 2017/01/04 10:11:46 | Recruitment status |
|
| 4 | Update | 2022/11/13 16:57:51 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
| 5 | Update | 2022/11/13 17:00:01 | Recruitment status Date of IRB Last follow-up date |
